In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Abbott Labs (ABT – Research Report), with a price target of $140.00. The company's shares closed last Tuesday at $115.08. According to TipRanks.com, Thibault is a 4-star analyst with an average return of 9.7% and a 30.2% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. Abbott Labs has an analyst consensus of Strong Buy, with a price target consensus of $139.38, which is a 19.4% upside from current levels.
https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-abbott-labs-abt?utm_source=advfn.com&utm_medium=referral
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Jul 2022 bis Aug 2022 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Aug 2021 bis Aug 2022 Click Here for more Abbott Laboratories Charts.